+499.5%
MRNA vs BR
-29.1%
+528.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -3.4% | +1.1% | +0.3% |
| 7D | +5.5% | -5.3% | +10.8% | +9.8% |
| 30D | +158.7% | +6.4% | +152.3% | +157.1% |
| 3M | +182.1% | +13.6% | +168.5% | +180.8% |
| 6M | +151.8% | -6.7% | +158.5% | +152.3% |
| YTD | +393.6% | -21.1% | +414.7% | +395.2% |
| 1Y | +499.5% | -29.6% | +529.0% | +537.8% |
| All | +499.5% | -29.1% | +528.5% | +537.8% |
Cumulative growth
Daily Returns
Daily percentage return beside BR.
Daily Out/Under-Performance
Portfolio return minus BR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling